Methylcobalamin effects on diabetic neuropathy and nerve protein kinase C in rats

European Journal of Clinical Investigation

Volumn 41, Issue 4, 2011, Pages 442-450

  Mizukami, Hiroki ^a   Ogasawara, Saori ^a   Yamagishi, Shin Ichiro ^a   Takahashi, Kazunori ^a   Yagihashi, Soroku ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Diabetic rat; Methylcobalamin; Oxidative stress; Peripheral neuropathy; Protein kinase C

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; MECOBALAMIN; POLYOL; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AXOPLASM; BLOOD VESSEL WALL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETOGENESIS; ENDONEURIUM; MACROPHAGE; MALE; NERVE CONDUCTION; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHWANN CELL; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; MALE; NERVE TISSUE PROTEINS; NEURAL CONDUCTION; OXIDATIVE STRESS; PROTEIN KINASE C; RANDOM ALLOCATION; RATS; RATS, WISTAR; STATISTICS AS TOPIC; VITAMIN B 12;

EID: 79952491435     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02430.x     Document Type: Article

References (40)

1. Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging 2006;10:377-85.
2. Scalabrino G, Peracchi M. New insights into the pathophysiology of cobalamin deficiency. Trends Mol Med 2006;12:247-54.
3. Metz J. Cobalamin deficiency and the pathogenesis of nervous system disease. Annu Rev Nutr 1992;12:59-79.
4. Banerjee R, Ragsdale SW. The many faces of vitamin B12: catalysis by cobalamin-dependent enzymes. Annu Rev Biochem 2003;72:209-47.
5. Miller A, Korem M, Almog R, Galboiz Y. Vitamin B12, demyelination, remyelination and repair in multiple sclerosis. J Neurol Sci 2005;233:93-7.
6. Wang J, Dudman NP, Wilcken DE, Lynch JF. Homocysteine catabolism: levels of 3 enzymes in cultured human vascular endothelium and their relevance to vascular disease. Atherosclerosis 1992;97:97-106.
7. Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 2004;11(Suppl 1):S56-64.
8. Nguyen TT, Alibrahim E, Islam FM, Klein R, Klein BE, Cotch MF et al. Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis. Diabetes Care 2009;32:1704-9.
9. Hodis HN, Mack WJ, Dustin L, Mahrer PR, Azen SP, Detrano R et al BVAIT Research Group. High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial. Stroke 2009;40:730-6.
10. Shargorodsky M, Boaz M, Pasternak S, Hanah R, Matas Z, Fux A et al. Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis? Diabetes Metab Res Rev 2009;25:70-5.
11. Yaqub BA, Siddique A, Sulimani R. Effects of methylcobalamin on diabetic neuropathy. Clin Neurol Neurosurg 1992;94:105-11.
12. Kuwabara S, Nakazawa R, Azuma N, Suzuki M, Miyajima K, Fukutake T et al. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Intern Med 1999;38:472-5.
13. Sun Y, Lai MS, Lu CJ. Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials. Acta Neurol Taiwan 2005;14:48-54.
14. Yagihashi S, Tokui A, Kashiwamura H, Takagi S, Imamura K. In vivo effect of methylcobalamin on the peripheral nerve structure in streptozotocin diabetic rats. Horm Metab Res 1982;14:10-3.
15. Yagihashi S. Diabetic neuropathy and vitamin B12. In: Kobayashi T, Vitamins and Biofactors in Life Science Tokyo: Center for Academic Publications Japan; 1992: pp 122-125. J Nutr Sci Vitaminol, Tokyo, Special issue.
16. Sonobe M, Yasuda H, Hatanaka I, Terada M, Yamashita M, Kikkawa R et al. Methylcobalamin improves nerve conduction in streptozotocin-diabetic rats without affecting sorbitol and myo-inositol contents of sciatic nerve. Horm Metab Res 1988;20:717-8.
17. Eichberg J. Protein kinase C changes in diabetes: is the concept relevant to neuropathy? Int Rev Neurobiol 2002;50:61-82.
18. Das Evcimen N, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res 2007;55:498-510.
19. Casellini CM, Barlow PM, Rice AL, Casey M, Simmons K, Pittenger G et al. A 6-month randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy. Diabetes Care 2007;30:896-902.
20. Yagihashi S, Yamagishi SI, Wada Ri R, Baba M, Hohman TC, Yabe-Nishimura C et al. Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Brain 2001;124:2448-58.
21. Yamagishi S, Ogasawara S, Mizukami H, Yajima N, Wada R, Sugawara A et al. Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats. J Neurochem 2008;104:491-9.
22. Uehara K, Yamagishi S, Otsuki S, Chin S, Yagihashi S. Effects of polyol pathway hyperactivity on protein kinase C activity, nociceptive peptide expression, and neuronal structure in dorsal root ganglia in diabetic mice. Diabetes 2004;53:3239-47.
23. Alvi F, Idkowiak-Baldys J, Baldys A, Raymond JR, Hannun YA. Regulation of membrane trafficking and endocytosis by protein kinase C: emerging role of the pericentrion, a novel protein kinase C-dependent subset of recycling endosomes. Cell Mol Life Sci 2007;64:263-70.
24. Brognard J, Newton AC. PHLiPPing the switch on Akt and protein kinase C signaling. Trends Endocrinol Metab 2008;19:223-30.
25. Meier M, Menne J, Haller H. Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice. Diabetologia 2009;52:765-75.
26. Potenza MA, Gagliardi S, Nacci C, Carratu' MR, Montagnani M. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 2009;16:94-112.
27. Kim H, Sasaki T, Maeda K, Koya D, Kashiwagi A, Yasuda H. Protein kinase Cβ selective inhibitor LY333531 attenuates diabetic hyperalgesia through ameliorating cGMP level of dorsal root ganglion neurons. Diabetes 2003;52:2102-9.
28. Roberts RE, McLean WG. Protein kinase C isozyme expression in sciatic nerves and spinal cords of experimentally diabetic rats. Brain Res 1997;754:147-56.
29. Nakamura J, Kato K, Hamada Y, Nakayama M, Chaya S, Nakashima E et al. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. Diabetes 1999;48:2090-5.
30. Yamagishi S, Uehara K, Otsuki S, Yagihashi S. Differential influence of increased polyol pathway on protein kinase C expressions between endoneurial and epineurial tissues in diabetic mice. J Neurochem 2003;87:497-507.
31. Kamiya H, Nakamura J, Hamada Y, Nakashima E, Naruse K, Kato K et al. Polyol pathway and protein kinase C activity of rat Schwannoma cells. Diabetes Metab Res Rev 2003;19:131-9.
32. Hwang YC, Shaw S, Kaneko M, Redd H, Marrero MB, Ramasamy R. Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury. FASEB J 2005;19:795-7.
33. Yagihashi S, Mizukami H, Ogasawara S, Yamagishi S, Nukada H, Kato N et al. The role of the polyol pathway in acute kidney injury caused by hindlimb ischaemia in mice. J Pathol 2010;220:530-41.
34. Veber D, Mutti E, Tacchini L, Gammella E, Tredici G, Scalabrino G. Indirect down-regulation of nuclear NF-kappaB levels by cobalamin in the spinal cord and liver of the rat. J Neurosci Res 2008;86:1380-7.
35. Birch CS, Brasch NE, McCaddon A, Williams JH. A novel role for vitamin B(12): Cobalamins are intracellular antioxidants in vitro. Free Radic Biol Med 2009;47:184-8.
36. Yamatsu K, Yamanishi Y, Kaneko T, Ohkawa I. Pharmacological studies on degeneration and regeneration of the peripheral nerves. (2) Effects of methylcobalamin on mitosis of Schwann cells and incorporation of labeled amino acid into protein fractions of crushed sciatic nerve in rats. Nippon Yakurigaku Zasshi 1976;72:269-78.
37. Scalabrino G, Buccellato FR, Veber D, Mutti E. New basis of the neurotrophic action of vitamin B12. Clin Chem Lab Med 2003;41:1435-7.
38. Okada K, Tanaka H, Temporin K, Okamoto M, Kuroda Y, Moritomo H et al. Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model. Exp Neurol 2010;222:191-203.
39. Jian-bo L, Cheng-ya W, Jia-wei C, Xiao-lu L, Zhen-qing F, Hong-tai M. The preventive efficacy of methylcobalamin on rat peripheral neuropathy influenced by diabetes via neural IGF-1 levels. Nutr Neurosci 2010;13:79-86.
40. Jacobs RL, House JD, Brosnan ME, Brosnan JT. Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes 1998;47:1967-70.